Restructuring Charges	9 Months Ended
Restructuring Charges	Sep. 30, 2013
Restructuring Charges [Abstract]
Restructuring	Restructuring Charges During the three and nine month periods ended September 30, 2013, the Company recorded restructuring charges in continuing operations totaling $0.4 million and $0.7 million, respectively. The restructuring charges for the three month period ended September 30, 2013 consisted of severance related to the resignation of the former CFO and other employee severance. The restructuring charges for the nine month period ended September 30, 2013 consisted of severance related to the resignation of the former CEO and CFO and other employee severance. During the three and nine month periods ended September 30, 2012, the Company recorded restructuring charges totaling $0.0 million and $0.4 million, respectively. The restructuring charges consisted of employee severance. At September 30, 2013, $1.7 million related to restructuring charges are recorded in accrued expenses and $0.1 million are recorded as other long-term liabilities in the accompanying consolidated balance sheet. These amounts include $1.2 million related to Portamedic that have been retained by the Company after the sale of Portamedic. These accruals include severance and branch closure expenses.

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

+ References+ Details